Defining the optimal method for reporting prostate cancer grade and tumor extent on magnetic resonance/ultrasound fusion–targeted biopsies
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 76, 68-75
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate CancerJAMA, 2015
- Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound‐fusion biopsy for the diagnosis of prostate cancerBJU International, 2014
- Comparison of magnetic resonance imaging and ultrasound ( MRI‐US ) fusion‐guided prostate biopsies obtained from axial and sagittal approachesBJU International, 2014
- How good is post-biopsy multiparametric magnetic resonance imaging in detecting and characterising the index lesion of localised prostate cancer?Scandinavian Journal of Urology, 2014
- Utility of Multiparametric Magnetic Resonance Imaging Suspicion Levels for Detecting Prostate CancerJournal of Urology, 2013
- Prostate Cancer Diagnosis: Multiparametric MR-targeted Biopsy with Cognitive and Transrectal US–MR Fusion Guidance versus Systematic Biopsy—Prospective Multicenter StudyRadiology, 2013
- Correlation of Magnetic Resonance Imaging Tumor Volume with HistopathologyJournal of Urology, 2012
- What Information are Urologists Extracting from Prostate Needle Biopsy Reports and What do They Need for Clinical Management of Prostate Cancer?European Urology, 2005
- Preoperative prediction of Gleason grade in radical prostatectomy specimens: the influence of different Gleason grades from multiple positive biopsy sitesLaboratory Investigation, 2005
- Prostate Needle Biopsy ReportingAmerican Journal of Surgical Pathology, 2004